SNT Biotech

Executive Summary

SNT Biotech is a San Diego-based private diagnostics company founded in 2018 that develops innovative at-home health testing solutions, including colon cancer screening and HbA1c tests. By offering convenient, reliable, and affordable testing options, the company aims to improve health outcomes, close care gaps, enhance HEDIS scores, and promote health equity in underserved communities. The company's direct-to-consumer and partnership models position it well in the growing at-home diagnostics market, which is driven by increasing consumer demand for convenient healthcare and value-based care initiatives. With a focus on preventive health, SNT Biotech's products address high-prevalence conditions such as colorectal cancer and diabetes, enabling early detection and better disease management. Despite being in a competitive landscape with players like Everlywell and LetsGetChecked, SNT Biotech differentiates itself through its emphasis on health equity and partnering with healthcare organizations to reach vulnerable populations.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for Colon Cancer Screening Test60% success
• Q1 2027Partnership Agreement with Major Health Insurer for HbA1c Test50% success
• Q2 2027Launch of Expanded Product Line Including Cholesterol Test45% success